Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies (Tables)

v3.22.2.2
Significant Accounting Policies (Tables)
9 Months Ended
Oct. 31, 2022
Accounting Policies [Abstract]  
Summary of Cash, Cash Equivalents, and Restricted Cash

The following table provides a summary of (i) cash and cash equivalents and (ii) restricted cash in the condensed consolidated statements of cash flows as of the periods presented:

 

 

As of October 31,

 

 

 

2022

 

 

2021

 

 

 

(Amounts in thousands)

 

Cash and cash equivalents

 

$

14,498

 

 

$

17,551

 

Restricted cash

 

 

283

 

 

 

339

 

Total cash, cash equivalents and restricted cash

 

$

14,781

 

 

$

17,890

 

 

Restricted cash is included as a component of other assets in the condensed consolidated balance sheets.

 

 

 

As of January 31,

 

 

 

2022

 

 

2021

 

 

 

(Amounts in thousands)

 

Cash and cash equivalents

 

$

17,528

 

 

$

5,856

 

Restricted cash

 

 

328

 

 

 

228

 

Total cash, cash equivalents and restricted cash

 

$

17,856

 

 

$

6,084

 

Schedule of Anti-dilutive Securities Excluded from Computation of Net (Loss) Income Per Share

The number of common shares used in the computation of diluted net loss per share for the periods presented does not include the effect of the following potentially outstanding common shares because the effect would have been antidilutive:

 

 

 

For the Three Months Ended October 31,

 

 

For the Nine Months Ended October 31,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

 

 

(Amounts in thousands)

 

 

(Amounts in thousands)

 

Stock options

 

 

1,061

 

 

 

1,287

 

 

 

1,157

 

 

 

1,542

 

Performance stock units

 

 

15

 

 

 

 

 

 

 

 

 

 

Restricted stock units

 

 

1,224

 

 

 

273

 

 

 

287

 

 

 

120

 

Deferred stock units

 

 

 

 

 

62

 

 

 

 

 

 

41

 

 

 

 

2,300

 

 

 

1,622

 

 

 

1,444

 

 

 

1,703